LifeSci Venture Partners

LifeSci Venture Partners is a venture capital firm in New York that focuses on biotech and health sectors. Founded 2017 in New York, United States by Paul Yook, it invests in early stage ventures. Its portfolio companies include Cala Health, Biolinq, Attune Pharmaceuticals, Akero Therapeutics, Orasis Pharmaceuticals, and Allakos. As of March 2020, LifeSci Venture Partners has made seven investments. Their most recent investment was on May 21, 2019, when Cala Health raised $50M. LifeSci Venture Partners has had two exits, the most notable of which include Allakos and Akero Therapeutics.

LifeSci Venture Partners is a venture capitalventure capital firm in New York that focuses on biotech and health sectors. Founded 2017 in New York, United States by Paul Yook, it invests in early stage ventures. Its portfolio companies include Cala Health, Biolinq, Attune Pharmaceuticals, Akero Therapeutics, Orasis Pharmaceuticals, and Allakos. As of March 2020, LifeSci Venture Partners has made seven investments. Their most recent investment was on May 21, 2019, when Cala Health raised $50M. LifeSci Venture Partners has had two exits, the most notable of which include Allakos and Akero Therapeutics.